The Medication Myth Your Doctor Isn't Allowed to Tell You: Why Your Prescription is Only Half the Story
You leave the doctor's office with a script in hand, a plan in mind, and hope for a cure. You take the pill faithfull...
CYTOSAR-U INJECTION 100mg/ml (10ml vial) (Cytarabine)
$207.89
Active Ingredient : Cytarabine
Discover CYTOSAR-U INJECTION 100mg/ml, a powerful treatment for certain types of cancer. This medication helps inhibit cancer cell growth, providing a crucial option for patients undergoing chemotherapy.
Reliable shipping
Flexible returns
Dispensing Country : India
CYTOSAR-U Injection 100mg/ml (10ml vial) is a sterile, preservative-free chemotherapy medication containing Cytarabine as its active ingredient. It is primarily used in the treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and other hematologic malignancies. The solution is administered intravenously or intrathecally under strict medical supervision due to its potent therapeutic effects and potential side effects.
Each 10ml vial provides a concentrated dose of Cytarabine (100mg per ml), making it suitable for precise dosing based on patient-specific factors such as body weight, condition, and treatment protocol. The medication works by inhibiting DNA synthesis in rapidly dividing cancer cells, thereby slowing or stopping their growth.
- Indications: Approved for leukemia treatment, including induction therapy, consolidation, and maintenance phases. It may also be used in certain lymphomas and meningeal leukemia.
- Dosage & Administration: Dosage varies based on treatment regimen—common protocols include continuous IV infusion or subcutaneous injection. Intrathecal use requires special caution.
- Side Effects: May include myelosuppression (low blood counts), nausea, vomiting, diarrhea, mouth sores, and liver toxicity. Rare but serious effects include neurotoxicity and pulmonary complications.
- Precautions: Regular monitoring of blood counts, liver function, and neurological status is essential. Contraindicated in patients with hypersensitivity to Cytarabine or severe bone marrow suppression.
- Storage: Store at controlled room temperature (20-25°C). Protect from light and avoid freezing. Unopened vials remain stable until the expiration date.
CYTOSAR-U Injection is a critical component of many chemotherapy regimens, offering significant efficacy in combating aggressive blood cancers. Healthcare providers must carefully assess risks and benefits before administration, ensuring adherence to safety protocols to minimize adverse effects.
- Cytarabine (100mg/ml)
- Water for Injection
- Hydrochloric Acid (for pH adjustment)
- Sodium Hydroxide (for pH adjustment)
CYTOSAR-U INJECTION 100mg/ml (10ml vial) is a chemotherapy medication containing cytarabine, primarily used to treat certain types of leukemia and lymphoma. It is administered intravenously or subcutaneously under the supervision of a healthcare professional. Before use, ensure the vial is intact and the solution is clear, colorless, and free of particles. If any discoloration or particles are observed, do not use the product.
To prepare the injection, follow aseptic techniques. Using a sterile syringe, withdraw the required dose from the vial based on the patient's body surface area or weight, as prescribed by the physician. The dose is typically diluted in a compatible intravenous fluid, such as 0.9% sodium chloride or 5% dextrose solution, to achieve the desired concentration. Mix the solution gently to avoid foaming or degradation of the medication.
For intravenous administration, the diluted solution is usually infused over a period of 1 to 3 hours, depending on the treatment regimen. For subcutaneous administration, the undiluted solution is injected into the fatty tissue under the skin. The frequency and duration of administration vary based on the specific treatment protocol and the patient's response to therapy.
During administration, monitor the patient for adverse reactions, such as fever, nausea, vomiting, or signs of infection. Regular blood tests are necessary to monitor bone marrow function and adjust the dose if needed. Store the vials at room temperature (20°C to 25°C) and protect them from light. Do not freeze the medication. Dispose of any unused solution and medical waste according to local regulations and guidelines for hazardous materials.
You may also like
Our products are sourced directly from brands or authorized distributors.
